Stay updated on Omalizumab in Multi-Allergen OIT Clinical Trial

Sign up to get notified when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Omalizumab in Multi-Allergen OIT Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-06T09:12:37.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Changed the label for the update timestamp from 'Last Update Posted (Estimated)' to 'Last Update Posted' on the study record. This alters how update times are displayed but does not affect the underlying study data or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-01-22T09:28:59.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-15T05:15:13.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Added a Locations section listing study sites by state (Arkansas, California, Colorado, Georgia, Maryland, Massachusetts, New York, North Carolina, Pennsylvania, Texas) and updated the revision to v3.3.3.
    Difference
    0.7%
    Check dated 2025-12-24T15:26:59.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Publication section updated: added language that publications are provided voluntarily by the person entering information, and the revision label updated to v3.3.2 (replacing the previous phrasing about the study results). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:53:32.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Notice about lapse in government funding and operating status has been removed; the page no longer provides guidance to check current status on cc.nih.gov or opm.gov.
    Difference
    0.2%
    Check dated 2025-11-18T07:34:10.000Z thumbnail image

Stay in the know with updates to Omalizumab in Multi-Allergen OIT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.